These are links to recent news stories featuring Jatinder Lamba, Ph.D., and her research lab.
2024
Dr. Jatinder Lamba presented UF Health Cancer Center Top Influencer Award
Genetic score advances personalized treatment strategies with promising AML drug
2023
UF College of Pharmacy trainees earn abstract achievement awards at ASH Annual Meeting
This Test May Guide AML Therapy for Black Pediatric Patients
Using patients’ genetic profile to inform AML treatment could help reduce racial disparities
Discovery may improve treatment for some leukemia patients
Dr. Jatinder Lamba receives $3.3 million NCI grant for pediatric AML research
2022
Marrero, Marchi win abstract awards at the American Society of Hematology Annual Meeting
Celebrating Distinction ceremony recognizes endowed professors and chairs
UF-led research identifies genes involved in chemotherapy resistance in pediatric AML
2021
UF researchers develop genetic score to improve pediatric cancer treatments
Lamba lab trainees win poster awards at UF Health Cancer Center Research Symposium
Five UF College of Pharmacy faculty appointed to endowed professorships
Dr. Jatinder Lamba awarded $1.9 million grant to continue Acute Myeloid Leukemia study
Dr. Jatinder Lamba featured in story about UF Research Foundation Professors
2020
Dr. Jatinder Lamba named 2020 UF Research Foundation Professor
2019
Dr. Jatinder Lamba receives a Live Like Bella grant to study pediatric cancer
Leukemia and Lymphoma Society awards grant to support pediatric cancer research
Dr. Jatinder Lamba’s lab receives multiple research accolades
UF Pharmacy wins four abstract awards at ASH Annual Meeting
2017
UF researchers identify gene variant to personalize therapy for deadly form of leukemia
Bringing a leukemia treatment back to life with precision medicine
Potential biomarker for acute myeloid leukaemia therapy
CD33 Splicing Polymorphism and Response to Gemtuzumab Ozogamicin in AML
2015
To tailor cancer treatment: Study uses computer simulation to model patient cancer DNA
Online Publications:
CD33 directed therapy: Current and future perspective in acute myeloid leukemia (AML) (Sept. 2018)
Acute Myeloid Leukemia (AML) research and Application (April 20, 2018)
Acute Myeloid Leukemia and cytarabine pharmacogenomics (Feb 2, 2018)
Personalising antibody directed therapy in Acute Myeloid Leukaemia (AML) (Nov.2017)
The Genetic Puzzle: Why Do We Respond to Cancer Therapy?
An interview and our research on pharmacogenomics in leukemia (Paths to Precise Prescriptions) was highlighted in International Innovations Journal.